Biotech | April 20, 2022
Leading inhalation APIs expert Inke to triple production capacity
To meet the growing global demand for respiratory active pharmaceutical ingredients (APIs), Inke is to invest €9 million into its production plant to reinforce focus on inhalation micronised APIs
